HPV
Fujirebio Europe to Distribute Self-Screen Cervical Cancer Test
The test is designed to detect elevated methylation levels of cervical cancer biomarkers and may be used as a triage follow-up test of HPV-positive women.
Naveris Nabs $33.4M Series A Round Expansion to Further Commercialize Virus-Related Cancer Tests
The new funding brings the total investment in the firm to $51 million, which Naveris will use for commercialization of its NavDx assay.
Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval
The GynTect assay detects oncogenic DNA methylation markers from cervical smear samples following abnormal cancer-screen findings.
Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition
The RNAscope ISH Probe High Risk HPV test detects E6/E7 mRNA and is intended to help inform treatment selection in oropharyngeal squamous cell carcinoma patients.
New York State Approves Enzo Biochem HPV Molecular Test
Enzo expects to make several announcements related to other molecular laboratory-developed tests this year and provide a timeline for US FDA submissions.
Oct 28, 2021
Oct 12, 2021
Genematrix HPV Detection Test Nabs CE Mark
Feb 12, 2021
Apr 22, 2020
Roche Diagnostics Q1 Sales Essentially Flat
Mar 11, 2020